While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined oral contraceptives, intrauterine devices, progestin-only pills, or subdermal ...

At a Friday hearing, U.S. District Judge M. Casey Rodgers, of the Northern District of Florida, ordered supplemental briefs to Pfizer's summary judgment motion on federal preemption in light of the ...

THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.

Depo Provera’s label change comes amidst a flurry of over 2,000 lawsuits from women alleging that the contraceptive caused their meningiomas.

U.S. District Judge M. Casey Rodgers of the Northern District of Florida is overseeing more than 400 lawsuits alleging that Depo-Provera, an injectable birth control, has caused non-malignant brain ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...

When many women turned to Depo-Provera as a convenient birth control option, they had no idea it might carry life-altering risks. After years of injections, some began experiencing troubling symptoms ...

Depo-Provera, an injectable contraceptive, will come with a special warning that links prolonged use of the drug with bone density loss, the government said Wednesday. The Food and Drug Administration ...